Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
Public ClinicalTrials.gov record NCT02603107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to GS-9883/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
Study identification
- NCT ID
- NCT02603107
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 578 participants
Conditions and interventions
Conditions
Interventions
- RTV Drug
- ATV Drug
- DRV Drug
- COBI Drug
- ATV/co Drug
- DRV/co Drug
- FTC/TDF Drug
- ABC/3TC Drug
- B/F/TAF Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 19, 2015
- Primary completion
- May 14, 2017
- Completion
- Dec 22, 2019
- Last update posted
- Dec 28, 2020
2015 – 2019
United States locations
- U.S. sites
- 63
- U.S. states
- 23
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85012 | — |
| Not listed | Phoenix | Arizona | 85015 | — |
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90069 | — |
| Not listed | Newport Beach | California | 92663 | — |
| Not listed | Oakland | California | 94602 | — |
| Not listed | Sacramento | California | 95825 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Francisco | California | 94102 | — |
| Not listed | San Leandro | California | 94577 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Washington D.C. | District of Columbia | 20017 | — |
| Not listed | Washington D.C. | District of Columbia | 20036 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Fort Lauderdale | Florida | 33316 | — |
| Not listed | Ft. Pierce | Florida | 34982 | — |
| Not listed | Miami | Florida | 33133 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Orlando | Florida | 32803-1851 | — |
| Not listed | Pensacola | Florida | 32504 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Vero Beach | Florida | 32960 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Wilton Manors | Florida | 33305 | — |
| Not listed | Atlanta | Georgia | 30312 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Macon | Georgia | 31201 | — |
| Not listed | Honolulu | Hawaii | 96813 | — |
| Not listed | Chicago | Illinois | 60613 | — |
| Not listed | Chicago | Illinois | 60657 | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | New Orleans | Louisiana | 70112 | — |
| Not listed | Boston | Massachusetts | 01211 | — |
| Not listed | Springfield | Massachusetts | 1105 | — |
| Not listed | Berkley | Michigan | 48072 | — |
| Not listed | Minneapolis | Minnesota | 55407 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | St Louis | Missouri | 63139 | — |
| Not listed | Buffalo | New York | 14215 | — |
| Not listed | The Bronx | New York | 10467 | — |
| Not listed | The Bronx | New York | — | — |
| Not listed | Chapel Hill | North Carolina | 27599-7080 | — |
| Not listed | Charlotte | North Carolina | 28209 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | Huntersville | North Carolina | 28078 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Memphis | Tennessee | 38105 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Dallas | Texas | 75215 | — |
| Not listed | Dallas | Texas | 75219 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77098 | — |
| Not listed | Longview | Texas | 75605 | — |
| Not listed | Annandale | Virginia | 22003-7313 | — |
| Not listed | Seattle | Washington | 98104 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02603107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02603107 live on ClinicalTrials.gov.